Results 81 to 90 of about 2,707 (157)

Successful treatment of pre-extensively drug-resistant tuberculous meningoencephalomyelitis in pregnancy with a bedaquiline and delamanid-based regimen: a case report. [PDF]

BMC Infect Dis
Nie Q, Liu Y, Xiao F, Zhou Y, Fu T, Zheng L, Huang D, Tang Q, Liu T, Tao L.   +9 more
europepmc   +1 more source

Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho. [PDF]

Emerg Infect Dis
Seung KJ, Asfaw M, Kunda M, Maama-Maime LB, Makaka J, Mofolo M, Mpinda S, Ndayizigiye M, Omar SV, Prasad P, Rupasinghe P, Yarbrough C, Oyewusi L.   +12 more
europepmc   +1 more source

Reply to Liao <i>et al.</i>: Optimizing Levofloxacin Dosing for Multidrug-resistant Tuberculosis in Low-Fat-Free Mass Asian Populations. [PDF]

Am J Respir Crit Care Med
Phillips PPJ, Peloquin CA, Sterling TR, Mitnick CD, Horsburgh CR.   +4 more
europepmc   +1 more source

ETS revisión rápida delamanid 50mg tableta

, 2018
En base a la información revisada no se ha encontrado información disponible que implique modificación de la opinión emitida en el informe N° 02-2018 DIGEMID-DFAU-UFURM/MINSA, que justifica la utilización de Delamanid 50 mg tableta; la evidencia científica que muestra ventajas para su uso en pacientes adultos para el tratamiento de la tuberculosis ...
openaire   +2 more sources

Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies. [PDF]

J Clin Tuberc Other Mycobact Dis
Timboe K, Jackson JB, Becker GL.
europepmc   +1 more source

<i>In vitro</i> exposure to clofazimine can select for delamanid and pretomanid resistance in <i>Mycobacterium tuberculosis</i>. [PDF]

Antimicrob Agents Chemother
Rupasinghe P, Ismail N, Mulders W, Warren RM, Joseph L, Ngcamu D, Gwala T, Omar SV, Vereecken J, de Jong BC, Rigouts L, Borroni E, Cirillo DM, Schön T, Miotto P, Köser CU.   +15 more
europepmc   +1 more source

Real-world safety profile of novel anti-multidrug-resistant tuberculosis drugs: a disproportionality analysis based on the FAERS database. [PDF]

BMJ Open
Zhao L, Zeng L, Qian Y, Zhao W, Xie R.
europepmc   +1 more source

Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial. [PDF]

Contemp Clin Trials
Kendall MA, Hughes MD, Kim S, Aaron LA, Naini L, Suryavanshi N, Shah NS, Rouzier V, Hafkin J, Sise T, Beck J, Heckman BE, Haberer JE, Harrington M, Scarsi KK, Hesseling AC, Swindells S, Churchyard GJ, Gupta A.   +18 more
europepmc   +1 more source

Timing is everything for compassionate use of delamanid [PDF]

Nature Medicine, 2015
openaire   +2 more sources

Management of adverse events in TB care and active TB drug safety monitoring. [PDF]

Breathe (Sheff)
Ma'aruf SY, Sharma A, Fox S, Duarte R, Lange C, Tiberi S.   +5 more
europepmc   +1 more source